How Might 3D Mammography Affect Screening in Younger Women and Minorities?

Monday, September 26, 2016

A Miami Herald (9/22, Horton) article discusses the impact of breast tomosynthesis (3D mammography) on breast cancer screening in younger women. The Herald points out, “One in six breast cancers occur in women aged 40-49, according to the American College of Radiology and Society of Breast Imaging.” The Herald article also explores possible impacts of American Cancer Society breast cancer screening guidelines on minority women. 

Society of Breast Imaging Statement on National Cancer Research Summit

Tuesday, June 28, 2016
In advance of Wednesday’s National Cancer Research “Moonshot” Summit, convened by Vice President Joe Biden and the National Cancer Institute, the Society of Breast Imaging (SBI) applauds the effort to rapidly push for the medical progress needed to prevent, treat and cure all types of cancer. 

Society of Breast Imaging 2015 Annual Report

Tuesday, May 17, 2016

The Society of Breast Imaging published the first Annual Report to commemorate 2015 and the society's work. In 2015, SBI celebrated 30 years of service to patients and professionals in the breast imaging field. The annual report includes the size of the society, its recent accomplishments and its initiatives. 

The Unscientific Approach to the Latest USPSTF Mammography Guidelines

Thursday, February 25, 2016

SBI Past President and ACR Breast Imaging Commission Chair, Debra Monticciolo, MD, FSBI, FACR, discusses the USPSTF breast screening recommendations.

Effectiveness of Digital Breast Tomosynthesis Compared with Digital Mammography Outcomes Analysis from 3 Years of Breast Cancer Screening

Thursday, February 18, 2016
“Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography” was recently published in JAMA Oncology. In this study SBI Fellow Dr. Emily Conant and her colleagues found that the benefits of digital breast tomosynthesis (lower recall rates and increased cancer detection rates) are sustainable beyond the first screening. Equally, and perhaps more important, there were fewer interval cancers with tomosynthesis screening compared to standard digital mammography screening.